Microbot Market Cap from 2010 to 2024

MBOT Stock  USD 0.92  0.01  1.10%   
Microbot Medical Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap will likely drop to about 15.9 M in 2024. From the period from 2010 to 2024, Microbot Medical Market Cap quarterly data regression had r-value of (0.22) and coefficient of variation of  50.21. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
16.7 M
Current Value
15.9 M
Quarterly Volatility
17.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.7 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 302, Dividend Yield of 0.0 or PTB Ratio of 3.9. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
  
This module can also supplement various Microbot Medical Technical models . Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Latest Microbot Medical's Market Cap Growth Pattern

Below is the plot of the Market Cap of Microbot Medical over the last few years. It is Microbot Medical's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Pretty Stable
   Market Cap   
       Timeline  

Microbot Market Cap Regression Statistics

Arithmetic Mean34,568,074
Geometric Mean28,920,234
Coefficient Of Variation50.21
Mean Deviation14,921,076
Median33,336,038
Standard Deviation17,356,543
Sample Variance301.2T
Range52.9M
R-Value(0.22)
Mean Square Error308.6T
R-Squared0.05
Significance0.43
Slope(857,444)
Total Sum of Squares4217.5T

Microbot Market Cap History

202415.9 M
202316.7 M
202221.9 M
202153.3 M
202049 M
201943.4 M
2018M

About Microbot Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Microbot Medical income statement, its balance sheet, and the statement of cash flows. Microbot Medical investors use historical funamental indicators, such as Microbot Medical's Market Cap, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may use each financial statement separately, they are all related. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Microbot Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Microbot Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Microbot Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Market Cap16.7 M15.9 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Microbot Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Microbot Medical's short interest history, or implied volatility extrapolated from Microbot Medical options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Microbot Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Microbot Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Microbot Medical Stock. Highlighted below are key reports to facilitate an investment decision about Microbot Medical Stock:
Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Microbot Stock analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.05)
Return On Assets
(0.69)
Return On Equity
(1.82)
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.